» Articles » PMID: 38012570

Micro Electrical Fields Induced MSC-sEVs Attenuate Neuronal Cell Apoptosis by Activating Autophagy Via LncRNA MALAT1/miR-22-3p/SIRT1/AMPK Axis in Spinal Cord Injury

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2023 Nov 27
PMID 38012570
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) is a traumatic condition of the central nervous system that causes paralysis of the limbs. Micro electric fields (EF) have been implicated in a novel therapeutic approach for nerve injury repair and regeneration, but the effects of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles that are induced by micro electric fields (EF-sEVs) stimulation on SCI remain unknown. The aim of the present study was to investigate whether EF-sEVs have therapeutic effects a rat model of SCI. EF-sEVs and normally conditioned human umbilical cord mesenchymal stem cells-derived small extracellular vesicles (CON-sEVs) were collected and injected intralesionally into SCI model rats to evaluate the therapeutic effects. We detect the expression of candidate long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNA-MALAT1) in EF-sEVs and CON-sEVs. The targets and downstream effectors of lncRNA-MALAT1 were investigated using luciferase reporter assays. Using both in vivo and in vitro experiments, we demonstrated that EF-sEVs increased autophagy and decreased apoptosis after SCI, which promoted the recovery of motor function. We further confirmed that the neuroprotective effects of EF-sEVs in vitro and in vivo correlated with the presence of encapsulated lncRNA-MALAT1 in sEVs. lncRNA-MALAT1 targeted miR-22-3p via sponging, reducing miR-22-3p's suppressive effects on its target, SIRT1, and this translated into AMPK phosphorylation and increased levels of the antiapoptotic protein Bcl-2. Collectively, the present study identified that the lncRNA-MALAT1 in EF-sEVs plays a neuroprotective role via the miRNA-22-3p/SIRT1/AMPK axis and offers a fresh perspective and a potential therapeutic approach using sEVs to improve SCI.

Citing Articles

Sirtuin1 in Spinal Cord Injury: Regulatory Mechanisms, Microenvironment Remodeling and Therapeutic Potential.

Li J, Cui S, Li Y, Zhang C, Chang C, Jian F CNS Neurosci Ther. 2025; 31(2):e70244.

PMID: 39915897 PMC: 11802336. DOI: 10.1111/cns.70244.


Aptamer-Conjugated Exosomes Ameliorate Diabetes-Induced Muscle Atrophy by Enhancing SIRT1/FoxO1/3a-Mediated Mitochondrial Function.

Song J, Yang M, Xia L, Wang L, Wang K, Xiang Y J Cachexia Sarcopenia Muscle. 2025; 16(1):e13717.

PMID: 39871746 PMC: 11773161. DOI: 10.1002/jcsm.13717.


Neuron-derived Netrin-1 deficiency aggravates spinal cord injury through activating the NF-κB signaling pathway.

Qin X, Zhang X, He X, Xu H, Yao Q, Li Z Heliyon. 2024; 10(17):e37388.

PMID: 39290272 PMC: 11407054. DOI: 10.1016/j.heliyon.2024.e37388.


Research progress on long non‑coding RNAs in non‑infectious spinal diseases (Review).

Ma Z, Liu X, Zhang X, Li S, An J, Luo Z Mol Med Rep. 2024; 30(3).

PMID: 38994759 PMC: 11267249. DOI: 10.3892/mmr.2024.13288.

References
1.
Xiao S, Zhang Y, Liu Z, Li A, Tong W, Xiong X . Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neurosci Ther. 2023; 29(4):1094-1108. PMC: 10018110. DOI: 10.1111/cns.14085. View

2.
Chen Y, Fan Z, Dong Q . LncRNA SNHG16 promotes Schwann cell proliferation and migration to repair sciatic nerve injury. Ann Transl Med. 2021; 9(16):1349. PMC: 8422103. DOI: 10.21037/atm-21-3971. View

3.
Parittotokkaporn S . Smartphone generated electrical fields induce axon regrowth within microchannels following injury. Med Eng Phys. 2022; 105:103815. DOI: 10.1016/j.medengphy.2022.103815. View

4.
Zhu N, Ruan J, Yang X, Huang Y, Jiang Y, Wang Y . Triptolide improves spinal cord injury by promoting autophagy and inhibiting apoptosis. Cell Biol Int. 2019; 44(3):785-794. DOI: 10.1002/cbin.11273. View

5.
Jung B, Yang C, Lee S . Electroceutical and Bioelectric Therapy: Its Advantages and Limitations. Clin Psychopharmacol Neurosci. 2023; 21(1):19-31. PMC: 9889897. DOI: 10.9758/cpn.2023.21.1.19. View